Lipocine Inc (LPCN) 시세

LPCN under $10

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity

LPCN under $10

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

Bottom was in on the eighth

Added

Clueless

Forward split then, lol. Shelf offering! Dilution!

Yes but that is the exact opposite of a reverse split which is what you said. Reverse splits lower share count….

Increasing authorized shares can have the same end result as a split, meaning each share can be worth less, due to more shares.

Increasing authorized shares is not a reverse split ….

There is no reverse split vote!

Yes, I'm voting to reverse split.

There is no reverse split vote ….

Dilution, reverse split, recession and bankruptcy.

DRSRB!

Well, with the upcoming reverse split vote, if approved, leads to dilution, thereby pushing the stock price down.

I am amazed that LPCN is now 0.92. Testosterone replacement therapy is a large market. Will sales disappoint for a reason?

"I" am always amazed when a small cap BIO gets approval for their testosterone pill over a Big Pharma that stole it and gets nailed to cross makes their stock sink?, "I" guess girls with Testosterone and Males with LPCN so no MALES in this market/world? On Watch for some males...

This LPCN message board ROCKS!!!

In my last summary (Jan2022) the stock was under a dollar and now its looking strong, I am very bullish going forward with it. Not alot of downside ATM

28 of march TLANDO pdufa, 10th march financials, this stock may grow until the approval date and over.

28 march pdufa for TLANDO and 10th sec filling am I wrong? I think this stock is going to grow constantly until 28th of march and over.

Something, nothing, anything, everything!

You said ever thing and nothing. Perfect job done.

Yes, you are correct, in March 2022, Tlando can be marketed to the public.

I remember that March 2022 is when the exclusivity for Clarus was going to end and that we could then sell our oral testosterone pills called Tlando. That was a provisional FDA decision. Is this still the case?
Thanks

Shart!!!

If the news was good with the NASH data why is the stock flat to down?

Well the NASH news is out and the results are good.

Any time this month

When are we expecting NASH data? Thanks.

Someday this stock price will either go up or go down. I'm so glad I could help.

It's going to be a win win.

Do'h!

Actually things look pretty darn good! Lawsuit aside, our pipeline is intact & progressing. TLando will still gain full approval next March, partnership news imminent (possibly soon after A/S increase),
1144 results due in a couple months with no bad expectations... yeah I'd say things are looking pretty good!

Yes, things don't look good for Lipocine or its' investors.

https://ih.advfn.com/stock-market/NASDAQ/lipocine-LPCN/stock-news/85206412/clarus-therapeutics-defeats-lipocines-patent-infri

Quite the range today, 1.25 to 1.56.

Correction, huge volume today.

Wow, big volume today.

Not yet

Is there a date for the Clarus court case?

Do'h @ 1.38 now...
How low can she go?
She be going down~!

Are you still long on LPCN?
I Am Long.

How long have you been in LPCN?
I Came Across Lipocine in August of last year.

Do you care to share your average pps or number of shares?
I have bought and sold my holdings several times to place other trades, ultimately resulting in an increase in current shares held.

It appears that Lipocine has not interest in suing in court. What's the court status?
Court status is apparent, awaiting trial scheduling. Lipocine brought the suit against Clarus to sue in court.

I don't think Lipocine is going to get a favorable deal for marketing Tlando. Am I being too negative? When will we hear about a partnership?
It is my opinion the litigation against Clarus and/or Phase 2 1144 results would need to wrap up before a partnering announcement. However, talks are obviously ongoing per an overly excited birdy named Patel. TLando is a money maker, any partner will know that!



It is anybodys guess as to when a good catalyst will hit; analyst upgrade, pipeline news, partnership, trial, nash results, etc.. so my mention of selling to run trades is risky. But, I've been lucky with timing and I Only jump ship on damn good prospects of a daytrade or overnight hold. Long and short alike. You might try paper trading your position (no risk) to see how you do with that, then jump in sometime if you feel confident. No risk, no reward!

As for Long term vs under 12 month holds, taxes are not my concern. Profit is, and if I turn a buck into two and have to pay forty cents, I'm still sixty cents up!

G'luk

I wonder what the results of the court case are and when it will reported? Meanwhile the share price is going down, down, down, to the burning ring of fire...

It's a pretty substantial drop from 1.47 to 1.37 today. We'll see what the future holds for this.

Thanks Vance, thus far I think it's been proven that an r/s is not up for a vote, it's the dilution that's up for a vote.

Are you still long on LPCN?
How long have you been in LPCN?
Do you care to share your average pps or number of shares?

I'm not trying to be negative here, but here are some of my thoughts...

It's a shame that Tlando only got tentative approval, for marketing in March 2022, due to the fraudulent exclusivity of Jatenzo.

It appears that Lipocine has not interest in suing in court. What's the court status?

It appears that no one would want a 2 or 3 times per day Tlando pill, when Xtlando, with a once per day dose would be preferred.

It appears that no one, the FDA, patients, or big pharma has much if any interest in a T-booster pill.

I don't think Lipocine is going to get a favorable deal for marketing Tlando. Am I being too negative? When will we hear about a partnership?

Positive Nash results will be a bigger deal than Tlando, or at least a good catalyst. Unfortunately, I guess it wasn't tested on alcoholics livers, but if it treats fatty livers good, maybe it could be prescribed off label to alcoholics...

As of writing this, I'm not under water. I'm considering to bale out in full now and if I do that, I'm considering getting back in, in early 2023.

Also, the Biden Admin wants price controls/socialized medicine, which might even happen with another executive order, so lower profits for big pharma, hedge funds and us retail investors. As well as lower research capital for new drugs...

Drug costs can't just be fixed with price controls, they also need to lower NDA and SNDA costs with the FDA as well as somehow reduce the cost of drug trials.

I was under water for a,ong time on, LPCN after the FDA first reject Tlando, so I bought more and up above water now, but I mostly just see cash burning and delays here.

In the extremely long run LPCN could be a win, but if I stay in I think I'll go undwer water as the stock price tanks for the next year or so...

Am I'm being too negative and paranoid or am I being realistic. What are your thoughts?

Thank you.

You really ought to sell any shares you have in Lipocine if you believe there is any truth to your assessment.

Before or after the r/s and dilution?